FFO
GILD icon

Fortitude Family Office’s Gilead Sciences GILD Stock Holding History

Fortitude Family Office’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.2K Buy
690
+83
+14% +$10.9K 0.02% 194
2026
Q1 		$84.6K Buy
607
+203
+50% +$28.4K 0.02% 173
2025
Q4 		$49.6K Sell
404
-70
-15% -$8.51K 0.01% 247
2025
Q3 		$52.6K Buy
474
+1
+0.2% +$114 0.01% 237
2025
Q2 		$52.4K Sell
473
-36
-7% -$3.83K 0.02% 244
2025
Q1 		$57K Sell
509
-413
-45% -$42.6K 0.02% 204
2024
Q4 		$85.2K Buy
922
+93
+11% +$8.37K 0.03% 188
2024
Q3 		$69.5K Buy
829
+574
+225% +$43.8K 0.03% 196
2024
Q2 		$17.5K Hold
255
– – 0.01% 323
2024
Q1 		$18.7K Sell
255
-108
-30% -$8.3K 0.01% 288
2023
Q4 		$29.4K Buy
+363
New +$28.2K 0.02% 233

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fortitude Family Office's GILD Position: Q2 2026 in Review

Fortitude Family Office increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $10.9K and bringing the position to 690 shares worth $87.2K. The position accounts for 0.02% of the portfolio, ranked #194.

Fortitude Family Office first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fortitude Family Office held 690 shares of Gilead Sciences worth $87.2K as of Q2 2026.
  • Fortitude Family Office bought 83 Gilead Sciences shares in Q2 2026, an estimated $10.9K.
  • Gilead Sciences made up 0.02% of Fortitude Family Office's portfolio in Q2 2026, its #194 holding.
  • Fortitude Family Office first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.